Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Clin Cardiol
    July 2024
  1. RESHADMANESH T, Behnoush AH, Farajollahi M, Khalaji A, et al
    Circulating Levels of Calprotectin as a Biomarker in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Clin Cardiol. 2024;47:e24315.
    >> Share

  2. CHANG CC, Sung WT, Lu YW, Chuang MJ, et al
    Real-World Clinical Performance of a Novolimus-Eluting Stent Versus a Sirolimus-Eluting Stent.
    Clin Cardiol. 2024;47:e24317.
    >> Share

  3. ARJOMANDI RAD A, Tserioti E, Magouliotis DE, Vardanyan R, et al
    Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting.
    Clin Cardiol. 2024;47:e24307.
    >> Share

  4. HOU J, Sun Y, Wang H, Zhang L, et al
    Papillary Muscle Infarction by Cardiac MRI in Patients With Mitral Regurgitation.
    Clin Cardiol. 2024;47:e24312.
    >> Share

  5. HOSSEINPOUR A, Sood A, Kamalpour J, Zandi E, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.
    Clin Cardiol. 2024;47:e24314.
    >> Share

  6. CHAO H, Jun-Qing G, Hong Z, Zhen Q, et al
    Prognostic Value of Coronary Microvascular Dysfunction Assessed by Coronary Angiography-Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction.
    Clin Cardiol. 2024;47:e24318.
    >> Share

    June 2024
  7. LABAND W, Vaz I
    Incorporating multiple biomarkers to assess mortality risk in non-ST elevation myocardial infarction.
    Clin Cardiol. 2024;47:e24300.
    >> Share

  8. SHEN M, Osman K, Blumenthal DM, DeMuth K, et al
    Home Heart Hospital Associated With Reduced Hospitalizations and Costs Among High-Cost Patients With Cardiovascular Disease.
    Clin Cardiol. 2024;47:e24302.
    >> Share

  9. OFFEN S, Yang C, Saw J
    Spontaneous coronary artery dissection (SCAD): A contemporary review.
    Clin Cardiol. 2024;47:e24236.
    >> Share

  10. XUE Z, Ye M, Jiang H, Li D, et al
    The Effect of Different Statin-Based Lipid-Lowering Strategies on C-Reactive Protein Levels in Patients With Stable Coronary Artery Disease.
    Clin Cardiol. 2024;47:e24301.
    >> Share

  11. BASIT J, Ahmed M, Shafiq A, Zaheer Z, et al
    Temporal Trends in the Outcomes of Percutaneous Coronary Intervention With Zotarolimus Eluting Stents Versus Everolimus Eluting Stents: A Meta-Analysis of Randomized Controlled Trials.
    Clin Cardiol. 2024;47:e24306.
    >> Share

  12. CHEN W, Nie J, Zhang M, Zhu Z, et al
    The Plaque Analysis Classifies the Coronary Artery Disease-Reporting and Data System (CAD-RADS) Stenosis and Plaque Burden Categories: Association of the Plaque Features, Fat Attenuation Index, Coronary Computed Tomography Fractional Flow Reserve, and
    Clin Cardiol. 2024;47:e24305.
    >> Share

  13. ZHOU J, Wei C, Li G, He W, et al
    The involvement of circulating miR-146a and miR-27a in patients with atherosclerotic cardiovascular disease after SARS-CoV-2 infection.
    Clin Cardiol. 2024;47:e24274.
    >> Share

    May 2024
  14. LI H, Liu X, Wang X, Yang Q, et al
    Relationship between Thyroid Feedback Quantile-based Index and cardiovascular diseases in a population with normal thyroid function: Evidence from the National Health and Nutrition Examination Survey 2007-2012.
    Clin Cardiol. 2024;47:e24271.
    >> Share

  15. SHAH BUD, Raj R, Kaur P, Karim A, et al
    Association of transportation noise with cardiovascular diseases.
    Clin Cardiol. 2024;47:e24275.
    >> Share

  16. KHORSANDI M, Blumenthal RS, Blaha MJ, Kohli P, et al
    The ABCs of the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease.
    Clin Cardiol. 2024;47:e24284.
    >> Share

  17. ROZENBAUM Z, Chang MF, Wiley J, Gholam A, et al
    Safety of ultra-low contrast coronary angiography in patients with acute kidney injury.
    Clin Cardiol. 2024;47:e24282.
    >> Share

    April 2024
  18. BRZEZINSKI RY, Banai S, Katz Shalhav M, Stark M, et al
    The CRP troponin test (CTT) stratifies mortality risk in patients with non-ST elevation myocardial infarction (NSTEMI).
    Clin Cardiol. 2024;47:e24256.
    >> Share

  19. LIU Y, Li W, An S, Zhai Z, et al
    Relationship between 24 h blood pressure variability and mortality in acute myocardial infarction patients.
    Clin Cardiol. 2024;47:e24261.
    >> Share

  20. BEHNOUSH AH, Maleki S, Arzhangzadeh A, Khalaji A, et al
    Prediabetes and major adverse cardiac events after acute coronary syndrome: An overestimated concept.
    Clin Cardiol. 2024;47:e24262.
    >> Share

    March 2024
  21. LIU L, Du X, Wei X, Dong W, et al
    The combination of high-frequency QRS and ST-segment alterations during exercise stress tests enhanced the diagnostic efficacy for coronary artery disease.
    Clin Cardiol. 2024;47:e24254.
    >> Share

  22. PAN Y, Wu TT, Deng CJ, Yang Y, et al
    Smoking and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: A substudy from the randomized PATH-PCI trial.
    Clin Cardiol. 2024;47:e24214.
    >> Share

  23. LEI H, Zhu L, Zhang X
    Knowledge, attitude, and practice toward postoperative self-management among patients after percutaneous coronary intervention: A structural equation modeling analysis.
    Clin Cardiol. 2024;47:e24232.
    >> Share

    February 2024
  24. HAQ A, Walser-Kuntz E, Gamam A, Albers A, et al
    Clinical characteristics and statin eligibility of patients under 50 with ST-elevation myocardial infarction.
    Clin Cardiol. 2024;47:e24231.
    >> Share

  25. KLONER RA, Stanek E, Desai K, Crowe CL, et al
    The association of tadalafil exposure with lower rates of major adverse cardiovascular events and mortality in a general population of men with erectile dysfunction.
    Clin Cardiol. 2024;47:e24234.
    >> Share

  26. ERGUI I, Salama J, Hooda U, Ebner B, et al
    In-hospital outcomes in unhoused patients with cardiogenic shock in the United States: Insights from The National Inpatient Sample 2011-2019.
    Clin Cardiol. 2024;47:e24235.
    >> Share

  27. KAWADA T
    Comment on "Association of kidney disease index with all-cause and cardiovascular mortality among individuals with hypertension".
    Clin Cardiol. 2024;47:e24242.
    >> Share

  28. XIONG C, Yu Q, Gao F, Liu S, et al
    Prognostic significance of IL-18 in acute coronary syndrome patients.
    Clin Cardiol. 2024;47:e24229.
    >> Share

  29. LIU J, Zhao L, Zhang Y, Wang L, et al
    A higher non-HDL-C/HDL-C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Clin Cardiol. 2024;47:e24243.
    >> Share

  30. YANG Y, Dong YZ, Hou AX, Liu P, et al
    Establishment and validation of a prediction model for nonrecovery of left ventricular ejection fraction in acute myocardial infarction patients combined with decreased left ventricular ejection fraction.
    Clin Cardiol. 2024;47:e24212.
    >> Share

  31. WANG L, Huang S, Zhou Q, Dou L, et al
    The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis.
    Clin Cardiol. 2024;47:e24238.
    >> Share

  32. SUPPLES MW, Snavely AC, O'Neill JC, Ashburn NP, et al
    Sex and race differences in the performance of the European Society of Cardiology 0/1-h algorithm with high-sensitivity troponin T.
    Clin Cardiol. 2024;47:e24199.
    >> Share

  33. ZHAO Z, Fu Y, Lian H, Liu Y, et al
    Correlation between the serum FABP4, ANGPTL3, and ANGPTL4 levels and coronary artery disease.
    Clin Cardiol. 2024;47:e24246.
    >> Share

  34. ZENG JL, Chen JH, Zhang LW, Chen LC, et al
    Lactate dehydrogenase-to-albumin ratio: A superior inflammatory marker for predicting contrast-associated acute kidney injury after percutaneous coronary intervention.
    Clin Cardiol. 2024;47:e24219.
    >> Share

  35. KIM JH, Yoon YC, Kim YH, Park JI, et al
    Cardiovascular outcomes between dapagliflozin versus empagliflozin in patients with diabetes mellitus.
    Clin Cardiol. 2024;47:e24248.
    >> Share

    January 2024
  36. YEH JT, Huang CC, Leu HB, Yin WH, et al
    Fatty acid-binding protein-3 and renal function decline in patients with chronic coronary syndrome.
    Clin Cardiol. 2024;47:e24210.
    >> Share

  37. SABET HR, Ahmadi M, Akrami M, Motamed M, et al
    Effects of flaxseed supplementation on weight loss, lipid profiles, glucose, and high-sensitivity C-reactive protein in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
    Clin Cardiol. 2024;47:e24211.
    >> Share

  38. ALLESCHER J, Sinnecker D, von Goeldel B, Barthel P, et al
    QRS fragmentation does not predict mortality in survivors of acute myocardial infarction.
    Clin Cardiol. 2024;47:e24218.
    >> Share

  39. YIN R, Ye Z, You H, Wu Y, et al
    Elevated uric acid/albumin ratio as a predictor of poor coronary collateral circulation development in patients with non-ST segment elevation myocardial infarction.
    Clin Cardiol. 2024;47:e24215.
    >> Share

  40. NORDLUND D, Lav T, Jablonowski R, Khoshnood A, et al
    Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data.
    Clin Cardiol. 2024;47:e24216.
    >> Share

  41. MANSOURI MH, Mansouri P, Sadeghi M, Hashemi SM, et al
    Antianginal effects of empagliflozin in patients with type 2 diabetes and refractory angina; a randomized, double-blind placebo-controlled trial (EMPT-ANGINA Trial).
    Clin Cardiol. 2024;47:e24158.
    >> Share

  42. JIANG Z, Shao F, Hu J, Zhuang Q, et al
    Time-weighted blood pressure with cardiovascular risk among patients with or without diabetes.
    Clin Cardiol. 2024;47:e24213.
    >> Share

    December 2023
  43. WANG C, Liu S, Yang Y, Kamronbek R, et al
    Interleukin-4 and Interleukin-17 are associated with coronary artery disease.
    Clin Cardiol. 2023 Dec 25. doi: 10.1002/clc.24188.
    >> Share

  44. LI WJ, Xu HW
    The differences between patients with nonalcoholic fatty liver disease (NAFLD) and those without NAFLD, as well as predictors of functional coronary artery ischemia in patients with NAFLD.
    Clin Cardiol. 2023 Dec 18. doi: 10.1002/clc.24205.
    >> Share

    November 2023
  45. LI M, Wang Y, Li L, Wu W, et al
    Global myocardial work in coronary artery disease patients without regional wall motion abnormality: Correlation with Gensini-score.
    Clin Cardiol. 2023 Nov 28. doi: 10.1002/clc.24193.
    >> Share

  46. WANG H, Wu Q, Yang L, Chen L, et al
    Application of AMR in evaluating microvascular dysfunction after ST-elevation myocardial infarction.
    Clin Cardiol. 2023 Nov 24. doi: 10.1002/clc.24196.
    >> Share

  47. HUANG L, Wang A, Wu Z, Chen S, et al
    Life's essential 8 and risk of all-cause mortality in individuals with cardiovascular diseases: A prospective community-based study.
    Clin Cardiol. 2023 Nov 23. doi: 10.1002/clc.24119.
    >> Share

  48. LV H, Li X, Ren Z, Ma X, et al
    Intravascular lithotripsy: A novel option for severe calcification of coronary artery.
    Clin Cardiol. 2023 Nov 9. doi: 10.1002/clc.24186.
    >> Share

  49. GAVINA C, Seabra-Carvalho D, Aguiar C, Anastassopoulou A, et al
    Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
    Clin Cardiol. 2023 Nov 6. doi: 10.1002/clc.24183.
    >> Share

  50. WANG M, Hu Z, Miao L, Shi M, et al
    A systematic review of the applicability of emergency department assessment of chest pain score-accelerated diagnostic protocol for risk stratification of patients with chest pain.
    Clin Cardiol. 2023;46:1303-1309.
    >> Share

    October 2023
  51. PAN LH, Yan BY, Zhu J, Lu Q, et al
    Effects of using primary percutaneous coronary interventions on the incidence of new-onset atrial fibrillation following an acute myocardial infarction.
    Clin Cardiol. 2023 Oct 25. doi: 10.1002/clc.24167.
    >> Share

  52. LOUTATI R, Perel N, Bruoha S, Taha L, et al
    Troponin level at presentation as a prognostic factor among patients presenting with non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Oct 19. doi: 10.1002/clc.24166.
    >> Share

  53. BEATTY C, Richardson KP, Tran PMH, Satter KB, et al
    Multiplex analysis of inflammatory proteins associated with risk of coronary artery disease in type-1 diabetes patients.
    Clin Cardiol. 2023 Oct 11. doi: 10.1002/clc.24143.
    >> Share

  54. FALLAHZADEH A, Mehraban S, Mahmoodi T, Sheikhy A, et al
    Risk factor profile and outcomes of premature acute coronary syndrome after percutaneous coronary intervention: A 1-year prospective design.
    Clin Cardiol. 2023 Oct 11. doi: 10.1002/clc.24170.
    >> Share

  55. ZHU L, Chen Z, Jiang H, Wang P, et al
    Association of red blood cell distribution width and hemoglobin-to-RDW ratio with contrast-associated acute kidney injury in patients undergoing coronary angiography: A retrospective study.
    Clin Cardiol. 2023 Oct 4. doi: 10.1002/clc.24163.
    >> Share

    September 2023
  56. DI GIACOMO D, Ranieri J, Guerra F, Cilli E, et al
    Cardiovascular risk and biopsychosocial interplay: Association among hypertension, anxiety, and emotional dysregulation-observational study in primary care setting for efficient self-care.
    Clin Cardiol. 2023 Sep 28. doi: 10.1002/clc.24152.
    >> Share

  57. ZHONG D, Cheng H
    Application of Mendelian randomization in the discovery of risk factors for coronary heart disease from 2009 to 2023: A bibliometric review.
    Clin Cardiol. 2023 Sep 19. doi: 10.1002/clc.24154.
    >> Share

  58. LI JQ, An Y, Wang T, Guo PX, et al
    Relationship between ideal cardiovascular health score and perioperative acute kidney injury: A case-control study.
    Clin Cardiol. 2023 Sep 19. doi: 10.1002/clc.24159.
    >> Share

  59. TOFIGHI S, Poorhosseini H, Jenab Y, Alidoosti M, et al
    Comparison of machine-learning models for the prediction of 1-year adverse outcomes of patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
    Clin Cardiol. 2023 Sep 18. doi: 10.1002/clc.24157.
    >> Share

  60. WIENEKE H, Voigt I
    Principles of artificial intelligence and its application in cardiovascular medicine.
    Clin Cardiol. 2023 Sep 18. doi: 10.1002/clc.24148.
    >> Share


  61. Correction to "Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry".
    Clin Cardiol. 2023 Sep 11. doi: 10.1002/clc.24150.
    >> Share

  62. XU L, Pinxten W, Vandereyt F, Falter M, et al
    Motivational communication skills to improve motivation and adherence in cardiovascular disease prevention: A narrative review.
    Clin Cardiol. 2023 Sep 7. doi: 10.1002/clc.24128.
    >> Share

  63. XU H, Qiao S, Cui J, Yuan J, et al
    Drug-eluting stent and drug-coated balloon for the treatment of de novo diffuse coronary artery disease lesions: A retrospective case series study.
    Clin Cardiol. 2023 Sep 4. doi: 10.1002/clc.24140.
    >> Share

  64. FAN H, Zhao J, Mao S, Wang Y, et al
    Circulating Th17/Treg as a promising biomarker for patients with rheumatoid arthritis in indicating comorbidity with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2023 Sep 4. doi: 10.1002/clc.24065.
    >> Share

  65. LI F, Wang S, Wang Y, Wei C, et al
    Long-term safety of ultrathin bioabsorbable-polymer sirolimus-eluting stents versus thin durable-polymer drug-eluting stents in acute coronary syndrome: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Sep 3. doi: 10.1002/clc.24139.
    >> Share

    August 2023
  66. SONG L, Li Y, Nie S, Feng Z, et al
    Using machine learning to predict adverse events in acute coronary syndrome: A retrospective study.
    Clin Cardiol. 2023 Aug 31. doi: 10.1002/clc.24127.
    >> Share

  67. FANG S, Chen Y, Gao Q, Wei Q, et al
    Association of kidney disease index with all-cause and cardiovascular mortality among individuals with hypertension.
    Clin Cardiol. 2023 Aug 21. doi: 10.1002/clc.24131.
    >> Share

  68. WANG L, Liu J, Fang H, Wang X, et al
    Factors associated with participation in cardiac rehabilitation in patients with acute myocardial infarction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Aug 18. doi: 10.1002/clc.24130.
    >> Share

  69. MA X, Zhang H, Tian Y, Wang Y, et al
    Mediating effect of depression on the association between cardiovascular disease and the risk of all-cause mortality: NHANES in 2005-2018.
    Clin Cardiol. 2023 Aug 18. doi: 10.1002/clc.24103.
    >> Share

  70. DANG W, Cao N, Zhang Y, Li W, et al
    Association among beta2-adrenergic receptor autoantibodies and proximal left anterior descending artery lesions in patients with initial ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Aug 17. doi: 10.1002/clc.24129.
    >> Share

  71. LI F, Zhang Y, Pan L, Chen H, et al
    Effects of dietary patterns on the all-cause mortality and cardiovascular disease mortality in patients with hypertension: A cohort study based on the NHANES database.
    Clin Cardiol. 2023 Aug 16. doi: 10.1002/clc.24118.
    >> Share

  72. CHEN J, Li J, Yue YH, Liu Y, et al
    Nomogram for predicting coronary artery lesions in patients with Kawasaki disease.
    Clin Cardiol. 2023 Aug 4. doi: 10.1002/clc.24113.
    >> Share

    July 2023
  73. LI Y, Zhang Y, Xiao K, Si J, et al
    The incidence of subclinical atherosclerosis in subjects with low and moderate cardiovascular risk.
    Clin Cardiol. 2023 Jul 31. doi: 10.1002/clc.24087.
    >> Share

  74. TABAGHI S, Sheibani M, Khaheshi I, Miri R, et al
    Associations between Short-Term Exposure to Fine Particulate Matter and Acute Myocardial Infarction: A Case-Crossover Study.
    Clin Cardiol. 2023 Jul 28. doi: 10.1002/clc.24111.
    >> Share


  75. Correction to "Atherosclerosis imaging quantitative computed tomography (AI-QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial".
    Clin Cardiol. 2023 Jul 27. doi: 10.1002/clc.24083.
    >> Share

  76. LEE W, Kang SH, Kim SH, Lee SY, et al
    Impact of dementia and drug compliance on patients with acute myocardial infarction.
    Clin Cardiol. 2023 Jul 24. doi: 10.1002/clc.24091.
    >> Share

  77. SENTHIL KUMARAN S, Del Cid Fratti J, Desai A, Garg R, et al
    Racial disparities in women with ST elevation myocardial infarction: A National Inpatient Sample review of baseline characteristics, co-morbidities, and outcomes in women with STEMI.
    Clin Cardiol. 2023 Jul 13. doi: 10.1002/clc.24068.
    >> Share

  78. ZEPPILLI P, Bianco M, Gervasi SF, Cammarano M, et al
    Congenital coronary artery anomalies in sports medicine. Why to know them.
    Clin Cardiol. 2023 Jul 11. doi: 10.1002/clc.24084.
    >> Share

  79. SUN Y, Ren J, Wang W, Wang C, et al
    Predictive value of CHA(2) DS(2) -VASc score for in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary PCI.
    Clin Cardiol. 2023 Jul 10. doi: 10.1002/clc.24071.
    >> Share

    June 2023
  80. VAN STEENBERGEN GJ, Demandt JPA, Schulz DN, Tonino PA, et al
    Direct admission versus interhospital transfer for revascularisation in non-ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Jun 21. doi: 10.1002/clc.24060.
    >> Share

  81. NOBAH AMA, Abuheit EMI, Jian L, Wang X, et al
    Clinical assessment of VSR site and size and its relation to the severity of heart failure in post-myocardial infarction ventricular septal rupture patients.
    Clin Cardiol. 2023 Jun 20. doi: 10.1002/clc.24062.
    >> Share

  82. KATAOKA N, Imamura T
    Impact of implantable cardioverter defibrillator on survival in patients with non-ischemic dilated cardiomyopathy.
    Clin Cardiol. 2023 Jun 12. doi: 10.1002/clc.24032.
    >> Share

  83. HUANG H, Leung KSK, Garg T, Mazzoleni A, et al
    Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID-19 pandemic.
    Clin Cardiol. 2023 Jun 1. doi: 10.1002/clc.24059.
    >> Share

    May 2023
  84. ROMANO S, Minardi S, Patrizi G, Palama Z, et al
    Sport in ischemic heart disease: Focus on primary and secondary prevention.
    Clin Cardiol. 2023 May 28. doi: 10.1002/clc.24052.
    >> Share

  85. MU X, Qiu M, Li Y, Li Z, et al
    N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA(2) DS(2) -VASc risk score for long-term cardiovascular events in acute coronary syndrome patients with atrial fibrillation.
    Clin Cardiol. 2023 May 22. doi: 10.1002/clc.24037.
    >> Share

  86. GONG X, Hua R, Bai J, Wu T, et al
    Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial.
    Clin Cardiol. 2023 May 16. doi: 10.1002/clc.24025.
    >> Share

  87. CHEN T, Liu Y, Zhang J, Sun Z, et al
    Percutaneous closure of ventricular septal rupture after myocardial infarction: A retrospective study of 81 cases.
    Clin Cardiol. 2023 May 15. doi: 10.1002/clc.24027.
    >> Share

    April 2023
  88. LIU R, Liu H, Yuan D, Chen Y, et al
    For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?-A 5-year follow-up cohort study.
    Clin Cardiol. 2023 Apr 28. doi: 10.1002/clc.24021.
    >> Share

  89. WANG H, Li L, Ma Y
    Platelet-to-lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24002.
    >> Share

  90. WANG B, Liu X, Hao W, Fan J, et al
    Comorbid obstructive sleep apnea is associated with adverse cardiovascular outcomes in female patients with acute coronary syndrome complicating metabolic syndrome.
    Clin Cardiol. 2023 Apr 14. doi: 10.1002/clc.24020.
    >> Share

  91. WANG Y, Sun J, Sun K, Li L, et al
    ECG-based cardiodynamicsgram can reflect anomalous functional information in coronary artery disease.
    Clin Cardiol. 2023 Apr 6. doi: 10.1002/clc.24019.
    >> Share

  92. VERVAAT FE, van der Gaag A, Smetsers C, Barneveld PC, et al
    Design and rationale of the efficacy of spinal cord stimulation in patients with refractory angina pectoris (SCRAP) trial.
    Clin Cardiol. 2023 Apr 4. doi: 10.1002/clc.24016.
    >> Share

  93. CATAPANO AL, De Caterina R, Jukema JW, Klempfner R, et al
    Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative.
    Clin Cardiol. 2023;46:407-415.
    >> Share

    March 2023
  94. KHALAJI A, Ajam A, Sheikhy A, Behnoush AH, et al
    Mortality across the spectrum of hemoglobin level in patients undergoing surgical coronary revascularization.
    Clin Cardiol. 2023 Mar 23. doi: 10.1002/clc.24004.
    >> Share

  95. ZHANG C, Zeng S, Ji W, Li Z, et al
    Synergistic role of circulating CD14++CD16+ monocytes and fibrinogen in predicting the cardiovascular events after myocardial infarction.
    Clin Cardiol. 2023 Mar 22. doi: 10.1002/clc.24005.
    >> Share

  96. YI C, Junyi G, Fengju L, Qing Z, et al
    Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients.
    Clin Cardiol. 2023 Mar 10. doi: 10.1002/clc.24003.
    >> Share

  97. WADA S, Iwanaga Y, Nakai M, Nakao YM, et al
    Combination of coronary CT angiography, FFR(CT) , and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD.
    Clin Cardiol. 2023 Mar 1. doi: 10.1002/clc.23989.
    >> Share

  98. WANG B, Gao Y, Zhao Y, Xu C, et al
    The spectrum of angiography-derived IMR according to morphological and physiological coronary stenosis in patients with suspected myocardial ischemia.
    Clin Cardiol. 2023 Mar 1. doi: 10.1002/clc.23999.
    >> Share

    February 2023
  99. KIM Y, Choi AD, Telluri A, Lipkin I, et al
    Atherosclerosis Imaging Quantitative Computed Tomography (AI-QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial.
    Clin Cardiol. 2023 Feb 27. doi: 10.1002/clc.23995.
    >> Share

  100. DEAN YE, Shebl MA, Rouzan SS, Bamousa BAA, et al
    Association between insomnia and the incidence of myocardial infarction: A systematic review and meta-analysis.
    Clin Cardiol. 2023 Feb 25. doi: 10.1002/clc.23984.
    >> Share

  101. LIU ES, Yang TH, Tai TH, Chiang CH, et al
    Long-term outcomes after stent implantation in very small vessel coronary artery disease.
    Clin Cardiol. 2023 Feb 23. doi: 10.1002/clc.24000.
    >> Share

  102. YOUN YJ, Jeon HS, Kim YI, Lee JH, et al
    Impact of the ultra-long 48 mm drug-eluting stent on procedural and clinical outcomes in patients with diffuse long coronary artery disease.
    Clin Cardiol. 2023 Feb 20. doi: 10.1002/clc.23997.
    >> Share

  103. CHEN W, Lin G, Dai C, Xu K, et al
    Predictive value of serum iron on heart failure in patients with acute ST-segment elevation myocardial infarction.
    Clin Cardiol. 2023 Feb 13. doi: 10.1002/clc.23990.
    >> Share

  104. DESAI R, Fadah K, Srikanth S, Neha NFN, et al
    Fibrinogen-albumin ratio predicting major adverse cardiovascular outcomes post-percutaneous coronary intervention: A systematic review and exploratory meta-analysis.
    Clin Cardiol. 2023 Feb 1. doi: 10.1002/clc.23981.
    >> Share

  105. JUSTO FA, de Deus Herrera B, Soares PR, Scudeler TL, et al
    Plato's allegory of the cave and the paradigm of complete revascularization in STEMI.
    Clin Cardiol. 2023;46:232-233.
    >> Share

    January 2023
  106. PARK HB, Lee J, Hong Y, Byungchang S, et al
    Risk factors based vessel-specific prediction for stages of coronary artery disease using Bayesian quantile regression machine learning method: Results from the PARADIGM registry.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23964.
    >> Share

  107. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Response to Mei et al. regarding the incidence and predictors of hospitalization for heart failure among patients with stable atherosclerosis in the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2023 Jan 24. doi: 10.1002/clc.23972.
    >> Share

  108. KODESH A, Bental T, Vaknin-Assa H, Talmor-Barkan Y, et al
    The independent impact of dementia in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    Clin Cardiol. 2023 Jan 12. doi: 10.1002/clc.23967.
    >> Share

  109. BEHNOUSH AH, Khalaji A, Rezaee M, Momtahen S, et al
    Machine learning-based prediction of 1-year mortality in hypertensive patients undergoing coronary revascularization surgery.
    Clin Cardiol. 2023 Jan 1. doi: 10.1002/clc.23963.
    >> Share

  110. AL-KASSOU B, Veulemans V, Shamekhi J, Maier O, et al
    Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience.
    Clin Cardiol. 2023;46:67-75.
    >> Share

    December 2022
  111. MOHAMMED AA, Zhang H, Abdu FA, Liu L, et al
    Effect of nonobstructive coronary stenosis on coronary microvascular dysfunction and long-term outcomes in patients with INOCA.
    Clin Cardiol. 2022 Dec 25. doi: 10.1002/clc.23962.
    >> Share

  112. LIN L, Huang J, Liu Z, Chen P, et al
    Associations of siesta and total sleep duration with hypertension or cardiovascular diseases in middle-aged and older adults.
    Clin Cardiol. 2022 Dec 12. doi: 10.1002/clc.23954.
    >> Share

  113. LUO F, Luo JY, Liu F, Qiu YJ, et al
    Coronary artery calcium and cystatin C for risk stratification of MACCEs and all-cause death in symptomatic patients.
    Clin Cardiol. 2022 Dec 9. doi: 10.1002/clc.23959.
    >> Share

  114. LI R, Shen L, Ma W, Yan B, et al
    Use of machine learning models to predict in-hospital mortality in patients with acute coronary syndrome.
    Clin Cardiol. 2022 Dec 7. doi: 10.1002/clc.23957.
    >> Share

  115. BONACA MP, Szarek M, Debus ES, Nehler MR, et al
    Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
    Clin Cardiol. 2022;45:1143-1146.
    >> Share

  116. SAADA M, Kobo O, Polad J, Halabi M, et al
    Prognosis of PCI in AMI setting in the elderly population: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Clin Cardiol. 2022;45:1211-1219.
    >> Share

    November 2022
  117. BROCKMEYER M, Wies E, Joerges J, Sommer J, et al
    Knowledge of HbA1c and LDL-C treatment goals, subjective level of disease-related information and information needs in patients with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2022 Nov 30. doi: 10.1002/clc.23948.
    >> Share

  118. LIMPIJANKIT T, Jongjirasiri S, Meemook K, Unwanatham N, et al
    Predictive values of coronary artery calcium and arterial stiffness for long-term cardiovascular events in patients with stable coronary artery disease.
    Clin Cardiol. 2022 Nov 29. doi: 10.1002/clc.23955.
    >> Share

  119. GAO Y, Guo Y, Dong J, Liu Y, et al
    Differences in the prevalence of cardiovascular and metabolic diseases coinciding with clinical subtypes of obstructive sleep apnea.
    Clin Cardiol. 2022 Nov 20. doi: 10.1002/clc.23941.
    >> Share

  120. BAGAI A, Ali FM, Gregson J, Alexander KP, et al
    Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registry.
    Clin Cardiol. 2022 Nov 1. doi: 10.1002/clc.23915.
    >> Share

  121. COTTER B, Raisinghani A, DeMaria AN
    Established and emerging roles for ultrasound enhancing agents (contrast echocardiography).
    Clin Cardiol. 2022;45:1114-1122.
    >> Share

    October 2022
  122. DESAI NR, Farbaniec M, Karalis DG
    Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease.
    Clin Cardiol. 2022 Oct 20. doi: 10.1002/clc.23935.
    >> Share

  123. CHENG Q, Zhou D, Wang J, Nie Z, et al
    Sex-specific risk factors of carotid atherosclerosis progression in a high-risk population of cardiovascular disease.
    Clin Cardiol. 2022 Oct 13. doi: 10.1002/clc.23931.
    >> Share

  124. MORTENSEN MB, Sand NP, Busk M, Jensen JM, et al
    Influence of intensive lipid-lowering on CT derived fractional flow reserve in patients with stable chest pain: Rationale and design of the FLOWPROMOTE study.
    Clin Cardiol. 2022;45:986-994.
    >> Share

    September 2022
  125. YU Q, Guo D, Peng J, Wu Q, et al
    Prevalence and adverse outcomes of frailty in older patients with acute myocardial infarction after percutaneous coronary interventions: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Sep 28. doi: 10.1002/clc.23929.
    >> Share

  126. IVEY SL, Hanley HR, Taylor C, Stock E, et al
    Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan utilizing policy levers.
    Clin Cardiol. 2022 Sep 20. doi: 10.1002/clc.23921.
    >> Share

  127. SHAIK A, Kosiborod M, de Lemos JA, Gao Q, et al
    Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23923.
    >> Share

  128. NAZER RI, Albarrati AM
    The brain-before-heart strategy for coronary artery bypass grafting in the severely atherosclerotic aorta: A single-institution experience.
    Clin Cardiol. 2022 Sep 19. doi: 10.1002/clc.23913.
    >> Share

  129. CHEN C, Li X, Su Y, You Z, et al
    Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: "Real-world" evidence.
    Clin Cardiol. 2022 Sep 18. doi: 10.1002/clc.23898.
    >> Share

  130. MANIAR Y, Blumenthal RS, Alfaddagh A
    The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC.
    Clin Cardiol. 2022 Sep 10. doi: 10.1002/clc.23918.
    >> Share

  131. YI M, Cao Q, Tang WH, Liu Q, et al
    Day-to-day fasting plasma glucose variability on the short-term prognosis of ST-segment elevation myocardial infarction: A retrospective cohort study.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23899.
    >> Share

  132. YAO H, Guo Q, Cheng Y, Zhu T, et al
    Predictors and morphological properties of culprit healed plaques in patients with angina pectoris.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23896.
    >> Share

  133. VALENTINE CM, Chazal RA
    Essential nonclinical competencies for cardiovascular specialists imperatives for training.
    Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23914.
    >> Share

  134. BRACEWELL NJ, Plasschaert J, Conti CR, Keeley EC, et al
    Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease.
    Clin Cardiol. 2022 Sep 2. doi: 10.1002/clc.23911.
    >> Share

  135. YANG Y, Hong Y, Yang W, Zheng Z, et al
    Association of lipoprotein(a) with aortic dissection.
    Clin Cardiol. 2022;45:908-912.
    >> Share

    August 2022
  136. SHARMA P, Shah K, Loomba J, Patel A, et al
    The impact of COVID-19 on clinical outcomes among acute myocardial infarction patients undergoing early invasive treatment strategy.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23908.
    >> Share

  137. MOTAWEA KR, Gaber H, Singh RB, Swed S, et al
    Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials.
    Clin Cardiol. 2022 Aug 30. doi: 10.1002/clc.23894.
    >> Share

    July 2022
  138. NAAMI R, Naami E, Omari T, Lowi SG, et al
    Cardiac rehabilitation performance predicts 1-year major adverse cardiovascular events.
    Clin Cardiol. 2022 Jul 29. doi: 10.1002/clc.23890.
    >> Share

  139. FREEDMAN BL, Berg DD, Scirica BM, Bohula EA, et al
    Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2 degrees P-TIMI 50 trial.
    Clin Cardiol. 2022 Jul 19. doi: 10.1002/clc.23843.
    >> Share

  140. ZDANYTE M, Martus P, Nestele J, Bild A, et al
    Risk assessment in COVID-19: Prognostic importance of cardiovascular parameters.
    Clin Cardiol. 2022 Jul 5. doi: 10.1002/clc.23883.
    >> Share

    June 2022
  141. WU C, Bu R, Wang Y, Xu C, et al
    Rehabilitation effects of circuit resistance training in coronary heart disease patients: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23855.
    >> Share

  142. LIMPIJANKIT T, Chandavimol M, Srimahachota S, Kanoksilp A, et al
    Dose-dependent effect of impaired renal function on all-cause mortality in patients following percutaneous coronary intervention.
    Clin Cardiol. 2022 Jun 27. doi: 10.1002/clc.23877.
    >> Share

  143. DE LUCA L, Calabro P, Chirillo F, Rolfo C, et al
    Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study.
    Clin Cardiol. 2022 Jun 22. doi: 10.1002/clc.23878.
    >> Share

  144. SCIRICA BM, Im K, Murphy SA, Kuder JF, et al
    Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Clin Cardiol. 2022 Jun 17. doi: 10.1002/clc.23844.
    >> Share

  145. WON KB, Park HB, Heo R, Lee BK, et al
    Longitudinal quantitative assessment of coronary atherosclerosis related to normal systolic blood pressure maintenance in the absence of established cardiovascular disease.
    Clin Cardiol. 2022 Jun 8. doi: 10.1002/clc.23870.
    >> Share

  146. SCOTT C, Lateef SS, Hong CG, Dey AK, et al
    Inflammation, coronary plaque progression, and statin use: A secondary analysis of the Risk Stratification with Image Guidance of HMG CoA Reductase Inhibitor Therapy (RIGHT) study.
    Clin Cardiol. 2022;45:622-628.
    >> Share

  147. MIYATA K, Asano T, Saito A, Abe K, et al
    Heart Team risk assessment with angiography-derived fractional flow reserve determining the optimal revascularization strategy in patients with multivessel disease: Trial design and rationale for the DECISION QFR randomized trial.
    Clin Cardiol. 2022;45:605-613.
    >> Share

    May 2022
  148. GAO L, Wang B, Cheng R
    Reply to comment on "Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis".
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23852.
    >> Share

  149. DENG JH, Zhang JX
    Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.
    Clin Cardiol. 2022 May 30. doi: 10.1002/clc.23851.
    >> Share

  150. YOU W, Zhou Y, Wu Z, Meng P, et al
    Post-PCI quantitative flow ratio predicts 3-year outcome after rotational atherectomy in patients with heavily calcified lesions.
    Clin Cardiol. 2022;45:558-566.
    >> Share

    April 2022
  151. MOTAMED N, Ajdarkosh H, Karbalaie Niya MH, Panahi M, et al
    Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.
    Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23827.
    >> Share

    March 2022
  152. MA R, Gao J, Mao S, Wang Z, et al
    Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.
    Clin Cardiol. 2022 Mar 30. doi: 10.1002/clc.23818.
    >> Share

  153. STOHR R, Dirrichs T, Kneizeh K, Reinartz S, et al
    Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.
    Clin Cardiol. 2022 Mar 25. doi: 10.1002/clc.23819.
    >> Share

  154. SUN M, Xing Y, Guo Y, Cao X, et al
    Left atrial reservoir strain is an outstanding predictor of adverse cardiovascular outcomes in patients undergoing maintenance hemodialysis: Assessment via three-dimensional speckle tracking echocardiography.
    Clin Cardiol. 2022 Mar 21. doi: 10.1002/clc.23815.
    >> Share

  155. HOU J, Sun Y, Zhang L, Wang W, et al
    Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23811.
    >> Share

  156. TOPPILA I, Ukkola-Vuoti L, Perttila J, Tornwall O, et al
    Cardiovascular event rate and death in high-risk secondary prevention patient cohort in Finland: A registry study.
    Clin Cardiol. 2022 Mar 15. doi: 10.1002/clc.23814.
    >> Share

  157. SUN L, Zhou M, Ji Y, Wang X, et al
    Off-pump versus on-pump coronary artery bypass grafting for octogenarians: A meta-analysis involving 146 372 patients.
    Clin Cardiol. 2022 Mar 10. doi: 10.1002/clc.23794.
    >> Share

  158. LUPU L, Taha L, Banai A, Shmueli H, et al
    Immediate and early percutaneous coronary intervention in very high-risk and high-risk non-ST segment elevation myocardial infarction patients.
    Clin Cardiol. 2022 Mar 9. doi: 10.1002/clc.23781.
    >> Share

  159. STEHLI J, Dinh D, Dagan M, Dick R, et al
    Sex differences in treatment and outcomes of patients with in-hospital ST-elevation myocardial infarction.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23797.
    >> Share

  160. XUE L, Yang YC, Zhao Q, Zhao ZH, et al
    The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
    >> Share

  161. WANG G, Zhao N, Zhong S, Wang H, et al
    Association of early repolarization pattern and ventricular fibrillation in patients with vasospastic angina: A systematic review and meta-analysis.
    Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23804.
    >> Share

  162. WEN XS, Luo R, Liu J, Liu ZQ, et al
    The duration of beta-blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study.
    Clin Cardiol. 2022 Mar 4. doi: 10.1002/clc.23807.
    >> Share

    February 2022
  163. LEE P, Brennan A, Dinh D, Stub D, et al
    The cost-effectiveness of radial access percutaneous coronary intervention: A propensity-score matched analysis of Victorian data.
    Clin Cardiol. 2022 Feb 22. doi: 10.1002/clc.23798.
    >> Share

  164. KNOERY C, McEwan KA, Manktelow M, Watt J, et al
    Using latent class analysis to identify clinical features of patients with occlusive myocardial infarction: Preangiogram prediction remains difficult.
    Clin Cardiol. 2022 Feb 8. doi: 10.1002/clc.23755.
    >> Share

  165. VRSALOVIC M, Vrsalovic Presecki A, Aboyans V
    Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta-analysis of adjusted observational studies.
    Clin Cardiol. 2022 Feb 7. doi: 10.1002/clc.23776.
    >> Share

  166. ZHAO Y, Zhou P, Gao W, Zhong H, et al
    Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantation.
    Clin Cardiol. 2022 Feb 4. doi: 10.1002/clc.23787.
    >> Share

  167. KATIKIREDDY CK, Samim A
    Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Clin Cardiol. 2022;45:152-161.
    >> Share

    January 2022
  168. XU J, Chen X, Xie Y, Lin J, et al
    Improvement of cardiac function after coronary artery bypass grafting surgery reduces the risk of postoperative acute kidney injury.
    Clin Cardiol. 2022 Jan 30. doi: 10.1002/clc.23785.
    >> Share

  169. LIN XL, Sun HX, Li FQ, Zhao JY, et al
    Admission high-sensitivity C-reactive protein levels improve the Grace risk score prediction on in-hospital outcomes in acute myocardial infarction patients.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23749.
    >> Share

  170. SANG DS, Zhang Q, Song D, Tao J, et al
    Association between brachial-ankle pulse wave velocity and cardiovascular and cerebrovascular disease in different age groups.
    Clin Cardiol. 2022 Jan 23. doi: 10.1002/clc.23777.
    >> Share

  171. YANG L, Zhu H, Sun Y, Yan P, et al
    Value of M2BP in predicting in-stent restenosis in patients after coronary drug-eluting stent implantation.
    Clin Cardiol. 2022 Jan 15. doi: 10.1002/clc.23775.
    >> Share

  172. CHI G, Lee JJ, Kazmi SHA, Fitzgerald C, et al
    Early and late recurrent cardiovascular events among high-risk patients with an acute coronary syndrome: Meta-analysis of phase III studies and implications on trial design.
    Clin Cardiol. 2022 Jan 12. doi: 10.1002/clc.23773.
    >> Share

  173. QIN Q, Chen L, Ge L, Qian J, et al
    A comparison of long-term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct-related artery after PCI of acute myocardial infarction.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23771.
    >> Share

  174. SHI Y, He S, Luo J, Jian W, et al
    Lesion characteristics and procedural complications of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery: A meta-analysis.
    Clin Cardiol. 2022 Jan 6. doi: 10.1002/clc.23766.
    >> Share

    December 2021
  175. ZHANG M, Zuo HJ, Yang HX, Nan N, et al
    Trends in conventional cardiovascular risk factors and myocardial infarction subtypes among young Chinese men with a first acute myocardial infarction.
    Clin Cardiol. 2021 Dec 28. doi: 10.1002/clc.23770.
    >> Share

  176. DALLI PEYDRO E, Sanz Sevilla N, Tuzon Segarra MT, Miro Palau V, et al
    A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome.
    Clin Cardiol. 2021 Dec 24. doi: 10.1002/clc.23757.
    >> Share

    November 2021
  177. DISSANAYAKE HU, Colpani JT, Sutherland K, Loke W, et al
    Obstructive sleep apnea therapy for cardiovascular risk reduction-Time for a rethink?
    Clin Cardiol. 2021 Nov 17. doi: 10.1002/clc.23747.
    >> Share

  178. XING Z, Wang X, Pei J, Zhu Z, et al
    The association of interferon-alpha with development of collateral circulation after artery occlusion.
    Clin Cardiol. 2021;44:1621-1627.
    >> Share

    October 2021
  179. DIAO K, Wang D, Chen Z, Wu X, et al
    Rationale and design of a multi-center, prospective randomized controlled trial on the effects of sacubitril-valsartan versus enalapril on left ventricular remodeling in ST-elevation myocardial infarction: The PERI-STEMI study.
    Clin Cardiol. 2021 Oct 20. doi: 10.1002/clc.23744.
    >> Share

  180. HOFER F, Kazem N, Schweitzer R, Horvat P, et al
    The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies.
    Clin Cardiol. 2021 Oct 19. doi: 10.1002/clc.23741.
    >> Share

  181. GONG Y, Li X, Ma X, Yu H, et al
    Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II.
    Clin Cardiol. 2021 Oct 15. doi: 10.1002/clc.23725.
    >> Share

  182. MOHAMED A
    Predicting mortality and no-reflow in STEMI patients using epicardial adipose tissue.
    Clin Cardiol. 2021;44:1371-1376.
    >> Share

    September 2021
  183. LIMPIJANKIT T, Vathesatogkit P, Matchariyakul D, Yingchoncharoen T, et al
    Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23735.
    >> Share

  184. CHEN G, Farris MS, Cowling T, Pinto L, et al
    Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real-world evidence study.
    Clin Cardiol. 2021 Sep 29. doi: 10.1002/clc.23732.
    >> Share

    August 2021
  185. KIM YK, Jang CW, Kwon SH, Kim JH, et al
    Ten-year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion.
    Clin Cardiol. 2021;44:1161-1168.
    >> Share

    July 2021
  186. TANG J, Hou H, Chu J, Chen F, et al
    Clinical implication of quantitative flow ratio to predict clinical events after drug-coated balloon angioplasty in patients with in-stent restenosis.
    Clin Cardiol. 2021;44:978-986.
    >> Share

    May 2021
  187. ECCLESTON DS, Kim JM, Ten Berg JM, Steg PG, et al
    The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic
    Clin Cardiol. 2021 May 27. doi: 10.1002/clc.23649.
    >> Share

    March 2021
  188. NARANG N, Dela Cruz M, Imamura T, Chung B, et al
    Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure.
    Clin Cardiol. 2021 Mar 18. doi: 10.1002/clc.23584.
    >> Share

  189. KONIGSTEIN M, Ponticelli F, Zivelonghi C, Merdler I, et al
    Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Clin Cardiol. 2021;44:424-428.
    >> Share

    February 2021
  190. HUANG W, Lim LMH, Aurangzeb AS, Wong CJ, et al
    Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification.
    Clin Cardiol. 2021;44:267-275.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016